Amalgamated Bank Sells 370 Shares of Plexus Corp. (NASDAQ:PLXS)

Amalgamated Bank cut its stake in shares of Plexus Corp. (NASDAQ:PLXS) by 4.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,000 shares of the technology company’s stock after selling 370 shares during the period. Amalgamated Bank’s holdings in Plexus were worth $1,094,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Quest Partners LLC lifted its position in shares of Plexus by 36,700.0% during the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock valued at $38,000 after buying an additional 367 shares in the last quarter. Innealta Capital LLC bought a new stake in Plexus during the 2nd quarter worth approximately $51,000. Farther Finance Advisors LLC lifted its holdings in Plexus by 89.4% during the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after purchasing an additional 219 shares in the last quarter. EntryPoint Capital LLC lifted its holdings in Plexus by 56.2% during the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after purchasing an additional 351 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Plexus by 190.1% in the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock worth $104,000 after purchasing an additional 498 shares during the period. Institutional investors own 94.45% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. KeyCorp initiated coverage on shares of Plexus in a research note on Tuesday, October 22nd. They set a “sector weight” rating on the stock. Benchmark boosted their price objective on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, October 28th. Needham & Company LLC upped their price objective on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday, October 25th. Finally, StockNews.com downgraded Plexus from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $133.50.

Insider Activity

In related news, COO Oliver K. Mihm sold 5,691 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $167.06, for a total value of $950,738.46. Following the sale, the chief operating officer now owns 19,585 shares in the company, valued at approximately $3,271,870.10. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CFO Patrick John Jermain sold 2,643 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $166.32, for a total value of $439,583.76. Following the completion of the sale, the chief financial officer now directly owns 21,959 shares of the company’s stock, valued at $3,652,220.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Oliver K. Mihm sold 5,691 shares of Plexus stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $167.06, for a total value of $950,738.46. Following the completion of the transaction, the chief operating officer now owns 19,585 shares of the company’s stock, valued at approximately $3,271,870.10. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,021 shares of company stock worth $6,285,388. 2.39% of the stock is currently owned by insiders.

Plexus Trading Down 2.9 %

Shares of Plexus stock opened at $155.88 on Thursday. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $169.41. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. The business has a 50-day moving average price of $138.13 and a 200-day moving average price of $121.57. The firm has a market cap of $4.24 billion, a price-to-earnings ratio of 38.87 and a beta of 0.87.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. The company had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.01 billion. Plexus had a return on equity of 9.51% and a net margin of 2.82%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.44 earnings per share. Equities research analysts anticipate that Plexus Corp. will post 6.13 EPS for the current fiscal year.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.